Julie C L Fournier

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Philip G Humphreys, Niall A Anderson, Paul Bamborough, Andrew Baxter, Chun-Wa Chung, Rosa Cookson, Peter D Craggs, Toryn Dalton, Julie C L Fournier, Laurie J Gordon, Heather F Gray, Matthew W Gray, Richard Gregory, David J Hirst, Craig J Jamieson, Katherine L Jones, Hripsimee Kessedjian, David Lugo, Grant McGonagle, Vipulkumar K Patel, Christopher Patten, Darren L Poole, Rab K Prinjha, Cesar Ramirez-Molina, Inmaculada Rioja, Gail Seal, Kayleigh A J Stafford, Rishi R Shah, Daniel Tape, Natalie H Theodoulou, Laura Tomlinson, Sabri Ukuser, Ian D Wall, Natalie Wellaway, Gemma White
Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432. Journal of medicinal chemistry 65 (22) (2022)
Julie C L Fournier, John P Evans, Francesca Zappacosta, Daniel A Thomas, Vipulkumar K Patel, Gemma V White, Sebastien Campos, Nicholas C O Tomkinson
Acetylation of the Catalytic Lysine Inhibits Kinase Activity in PI3Kδ. ACS chemical biology 16 (9) (2021)

Julie C L Fournier.css-eqlu8i{font-size:small;padding-left:4px;}